Catharus ustulatus isolate bCatUst1 chromosome 15, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020350.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
potassium voltage-gated channel interacting protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X11
COORDINATES: polyA evidence [ECO:0006239]
Kv channel-interacting protein 1 isoform X3
Kv channel-interacting protein 1 isoform X7
potassium voltage-gated channel interacting protein 1, transcript variant X17
potassium calcium-activated channel subfamily M regulatory beta subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium-activated potassium channel subunit beta-1
potassium voltage-gated channel interacting protein 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X12
potassium voltage-gated channel interacting protein 1, transcript variant X13
Kv channel-interacting protein 1 isoform X4
Kv channel-interacting protein 1 isoform X8
potassium voltage-gated channel interacting protein 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X16
potassium voltage-gated channel interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X10
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X6
potassium voltage-gated channel interacting protein 1, transcript variant X2
potassium voltage-gated channel interacting protein 1, transcript variant X9
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X5
potassium voltage-gated channel interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X7
Kv channel-interacting protein 1 isoform X9
potassium voltage-gated channel interacting protein 1, transcript variant X20
Kv channel-interacting protein 1 isoform X10
gamma-aminobutyric acid type A receptor subunit pi
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gamma-aminobutyric acid receptor subunit pi
kazal-type serine protease inhibitor domain-containing protein 1-like
RAN binding protein 17, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAN binding protein 17, transcript variant X8
RAN binding protein 17, transcript variant X4
RAN binding protein 17, transcript variant X11
RAN binding protein 17, transcript variant X6
RAN binding protein 17, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RAN binding protein 17, transcript variant X14
RAN binding protein 17, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RAN binding protein 17, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAN binding protein 17, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
RAN binding protein 17, transcript variant X13
RAN binding protein 17, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RAN binding protein 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RAN binding protein 17, transcript variant X16
RAN binding protein 17, transcript variant X3
RAN binding protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
F-box and WD repeat domain containing 11, transcript variant X4
F-box and WD repeat domain containing 11, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X5
F-box and WD repeat domain containing 11, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X3
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X4
eukaryotic translation termination factor 1
eukaryotic peptide chain release factor subunit 1
heat shock protein family A (Hsp70) member 9
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00154
leucine rich repeat transmembrane neuronal 2, transcript variant X1
leucine rich repeat transmembrane neuronal 2, transcript variant X3
leucine rich repeat transmembrane neuronal 2, transcript variant X2
leucine-rich repeat transmembrane neuronal protein 2 isoform X3
leucine-rich repeat transmembrane neuronal protein 2 isoform X2
leucine-rich repeat transmembrane neuronal protein 2 isoform X1
SIL1 nucleotide exchange factor, transcript variant X1
SIL1 nucleotide exchange factor, transcript variant X2
nucleotide exchange factor SIL1 isoform X1
nucleotide exchange factor SIL1 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00090
poly(A) binding protein interacting protein 2, transcript variant X1
poly(A) binding protein interacting protein 2, transcript variant X3
poly(A) binding protein interacting protein 2, transcript variant X2
polyadenylate-binding protein-interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
marginal zone B and B1 cell specific protein
marginal zone B- and B1-cell-specific protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 48% coverage of the annotated genomic feature by RNAseq alignments
DnaJ heat shock protein family (Hsp40) member C18
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endothelial cell-specific chemotaxis regulator isoform X2
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endothelial cell-specific chemotaxis regulator isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: proteinase-activated receptor 3-like
FCH and double SH3 domains 1, transcript variant X1
FCH and double SH3 domains 1, transcript variant X2
F-BAR and double SH3 domains protein 1 isoform X1
F-BAR and double SH3 domains protein 1 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC117003493
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 142 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 5 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-B5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 134 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 76 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 158 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 131 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin beta-2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin beta-16-like
protocadherin alpha-C2-like, transcript variant X4
protocadherin alpha-C2-like, transcript variant X1
protocadherin alpha-C2-like, transcript variant X2
protocadherin alpha-C2-like, transcript variant X5
protocadherin alpha-C2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 38 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histidine--tRNA ligase, cytoplasmic-like isoform X2
histidine--tRNA ligase, cytoplasmic-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like isoform X1
histidine--tRNA ligase, cytoplasmic-like
amyloid-beta A4 precursor protein-binding family B member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: steroid receptor RNA activator 1-like
eukaryotic translation initiation factor 4E-binding protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LOW QUALITY PROTEIN: eukaryotic translation initiation factor 4E-binding protein 3-like
ankyrin repeat and KH domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 71% coverage of the annotated genomic feature by RNAseq alignments
protocadherin alpha-C1-like, transcript variant X2
protocadherin alpha-C1-like, transcript variant X1
protocadherin alpha-C1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 29 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
protocadherin-10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protocadherin-10-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
amyloid beta precursor protein binding family B member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family B member 3
ankyrin repeat and KH domain-containing protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X9
ankyrin repeat and KH domain-containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1 isoform X11
ankyrin repeat and KH domain-containing protein 1 isoform X10
ankyrin repeat and KH domain-containing protein 1 isoform X9
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X1
ankyrin repeat and KH domain-containing protein 1, transcript variant X6
ankyrin repeat and KH domain-containing protein 1, transcript variant X8
ankyrin repeat and KH domain-containing protein 1, transcript variant X7
ankyrin repeat and KH domain-containing protein 1 isoform X8
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain-containing protein 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
heparin binding EGF like growth factor, transcript variant X2
heparin binding EGF like growth factor, transcript variant X3
heparin binding EGF like growth factor, transcript variant X1
proheparin-binding EGF-like growth factor
cysteine rich transmembrane module containing 1, transcript variant X1
cysteine rich transmembrane module containing 1, transcript variant X3
cysteine rich transmembrane module containing 1, transcript variant X2
cysteine-rich and transmembrane domain-containing protein 1 isoform X1
cysteine-rich and transmembrane domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 15 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
transcriptional activator protein Pur-alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pro-neuregulin-2, membrane-bound isoform isoform X3
pro-neuregulin-2, membrane-bound isoform isoform X4
pro-neuregulin-2, membrane-bound isoform isoform X1
pro-neuregulin-2, membrane-bound isoform isoform X2
CXXC finger protein 5, transcript variant X1
CXXC finger protein 5, transcript variant X2
stimulator of interferon response cGAMP interactor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
transmembrane and coiled-coil domain-containing protein 6
NADH:ubiquinone oxidoreductase subunit A2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
DND microRNA-mediated repression inhibitor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dedicator of cytokinesis 2, transcript variant X2
dedicator of cytokinesis 2, transcript variant X1
dedicator of cytokinesis protein 2 isoform X2
dedicator of cytokinesis protein 2 isoform X1
inhibitory synaptic factor family member 2B
spindle apparatus coiled-coil protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
spindle apparatus coiled-coil protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
spindle apparatus coiled-coil protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
spindle apparatus coiled-coil protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
slit guidance ligand 3, transcript variant X1
slit guidance ligand 3, transcript variant X3
slit guidance ligand 3, transcript variant X2
slit guidance ligand 3, transcript variant X4
slit guidance ligand 3, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 25 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pantothenate kinase 3
rho GTPase-activating protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X2
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like isoform X2
WW and C2 domain containing 1, transcript variant X1
WW and C2 domain containing 1, transcript variant X2
teneurin transmembrane protein 2, transcript variant X16
teneurin transmembrane protein 2, transcript variant X15
teneurin transmembrane protein 2, transcript variant X13
teneurin transmembrane protein 2, transcript variant X12
teneurin transmembrane protein 2, transcript variant X11
teneurin transmembrane protein 2, transcript variant X9
teneurin transmembrane protein 2, transcript variant X14
teneurin transmembrane protein 2, transcript variant X10
teneurin transmembrane protein 2, transcript variant X8
teneurin transmembrane protein 2, transcript variant X7
teneurin transmembrane protein 2, transcript variant X6
teneurin transmembrane protein 2, transcript variant X3
teneurin transmembrane protein 2, transcript variant X5
teneurin transmembrane protein 2, transcript variant X4
teneurin transmembrane protein 2, transcript variant X1
teneurin transmembrane protein 2, transcript variant X2
teneurin transmembrane protein 2, transcript variant X18
teneurin transmembrane protein 2, transcript variant X17
methionine adenosyltransferase 2 subunit beta
hyaluronan mediated motility receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
hyaluronan mediated motility receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
hyaluronan mediated motility receptor isoform X2
hyaluronan mediated motility receptor isoform X1
methionine adenosyltransferase 2 subunit beta, transcript variant X2
methionine adenosyltransferase 2 subunit beta, transcript variant X1
methionine adenosyltransferase 2 subunit beta isoform X2
methionine adenosyltransferase 2 subunit beta isoform X1
hyaluronan mediated motility receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X1
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-2 isoform X2
gamma-aminobutyric acid receptor subunit gamma-2 isoform X1
gamma-aminobutyric acid type A receptor subunit alpha1, transcript variant X1
gamma-aminobutyric acid type A receptor subunit alpha1, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-1
gamma-aminobutyric acid type A receptor subunit alpha6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor subunit alpha6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-6 isoform X1
gamma-aminobutyric acid receptor subunit alpha-6 isoform X2
gamma-aminobutyric acid receptor subunit beta-2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: gamma-aminobutyric acid receptor subunit beta-2-like
ATPase phospholipid transporting 10B (putative)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
PTTG1 regulator of sister chromatid separation, securin, transcript variant X1
PTTG1 regulator of sister chromatid separation, securin, transcript variant X2
SLU7 homolog, splicing factor, transcript variant X3
SLU7 homolog, splicing factor, transcript variant X4
SLU7 homolog, splicing factor, transcript variant X1
SLU7 homolog, splicing factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
sosondowah ankyrin repeat domain family member A
LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein SOWAHA
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
kinesin family member 3A, transcript variant X1
kinesin family member 3A, transcript variant X2
RAD50 double strand break repair protein, transcript variant X1
RAD50 double strand break repair protein, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X1
solute carrier family 22 member 5-like, transcript variant X2
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like isoform X2
solute carrier family 22 member 4, transcript variant X1
solute carrier family 22 member 4, transcript variant X2
solute carrier family 22 member 4 isoform X1
solute carrier family 22 member 4 isoform X2
prolyl 4-hydroxylase subunit alpha 2, transcript variant X2
prolyl 4-hydroxylase subunit alpha 2, transcript variant X3
prolyl 4-hydroxylase subunit alpha 2, transcript variant X1
prolyl 4-hydroxylase subunit alpha-2 isoform X2
prolyl 4-hydroxylase subunit alpha-2 isoform X1
acyl-CoA synthetase long chain family member 6, transcript variant X1
long-chain-fatty-acid--CoA ligase 6 isoform X1
acyl-CoA synthetase long chain family member 6, transcript variant X5
acyl-CoA synthetase long chain family member 6, transcript variant X2
acyl-CoA synthetase long chain family member 6, transcript variant X3
acyl-CoA synthetase long chain family member 6, transcript variant X4
long-chain-fatty-acid--CoA ligase 6 isoform X2
long-chain-fatty-acid--CoA ligase 6 isoform X3
long-chain-fatty-acid--CoA ligase 6 isoform X4
LOW QUALITY PROTEIN: meiosis-specific kinetochore protein
folliculin interacting protein 1, transcript variant X1
folliculin interacting protein 1, transcript variant X3
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X3
folliculin interacting protein 1, transcript variant X2
folliculin-interacting protein 1 isoform X2
Rap guanine nucleotide exchange factor 6, transcript variant X5
Rap guanine nucleotide exchange factor 6, transcript variant X10
Rap guanine nucleotide exchange factor 6, transcript variant X7
Rap guanine nucleotide exchange factor 6, transcript variant X2
Rap guanine nucleotide exchange factor 6, transcript variant X6
Rap guanine nucleotide exchange factor 6, transcript variant X11
Rap guanine nucleotide exchange factor 6, transcript variant X8
Rap guanine nucleotide exchange factor 6, transcript variant X1
Rap guanine nucleotide exchange factor 6, transcript variant X9
Rap guanine nucleotide exchange factor 6, transcript variant X3
Rap guanine nucleotide exchange factor 6, transcript variant X4
rap guanine nucleotide exchange factor 6 isoform X1
rap guanine nucleotide exchange factor 6 isoform X9
rap guanine nucleotide exchange factor 6 isoform X5
rap guanine nucleotide exchange factor 6 isoform X10
rap guanine nucleotide exchange factor 6 isoform X3
rap guanine nucleotide exchange factor 6 isoform X7
rap guanine nucleotide exchange factor 6 isoform X2
rap guanine nucleotide exchange factor 6 isoform X6
rap guanine nucleotide exchange factor 6 isoform X11
rap guanine nucleotide exchange factor 6 isoform X4
rap guanine nucleotide exchange factor 6 isoform X8
Rap guanine nucleotide exchange factor 6, transcript variant X12
Rap guanine nucleotide exchange factor 6, transcript variant X13
rap guanine nucleotide exchange factor 6 isoform X12
follistatin like 4, transcript variant X2
follistatin like 4, transcript variant X3
follistatin like 4, transcript variant X1
follistatin-related protein 4 isoform X2
follistatin-related protein 4 isoform X1
keratinocyte-associated transmembrane protein 2
voltage-dependent anion-selective channel protein 1
transcription factor 7, transcript variant X1
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X4
S-phase kinase associated protein 1, transcript variant X2
S-phase kinase associated protein 1, transcript variant X1
protein phosphatase 2 catalytic subunit alpha
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
jade family PHD finger 2, transcript variant X1
jade family PHD finger 2, transcript variant X2
E3 ubiquitin-protein ligase Jade-2 isoform X1
E3 ubiquitin-protein ligase Jade-2 isoform X2
secretion associated Ras related GTPase 1B, transcript variant X1
secretion associated Ras related GTPase 1B, transcript variant X2
SEC24 homolog A, COPII coat complex component, transcript variant X1
SEC24 homolog A, COPII coat complex component, transcript variant X2
SEC24 homolog A, COPII coat complex component, transcript variant X3
protein transport protein Sec24A isoform X1
protein transport protein Sec24A isoform X2
protein transport protein Sec24A isoform X3
calcium modulating ligand, transcript variant X1
guided entry of tail-anchored proteins factor CAMLG isoform X1
calcium modulating ligand, transcript variant X2
guided entry of tail-anchored proteins factor CAMLG isoform X2
probable ATP-dependent RNA helicase DDX46
chromosome 15 C5orf24 homolog, transcript variant X1
chromosome 15 C5orf24 homolog, transcript variant X2
chromosome 15 C5orf24 homolog, transcript variant X3
UPF0461 protein C5orf24 homolog isoform X2
UPF0461 protein C5orf24 homolog isoform X1
thioredoxin domain-containing protein 15
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X1
pterin-4-alpha-carbinolamine dehydratase 2 isoform X1
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X2
pterin-4-alpha-carbinolamine dehydratase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X2
core histone macro-H2A.1, transcript variant X1
core histone macro-H2A.1, transcript variant X4
core histone macro-H2A.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
transforming growth factor-beta-induced protein ig-h3
SMAD family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SMAD family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 11 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
SMAD family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 ESTs, 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mothers against decapentaplegic homolog 5
transient receptor potential cation channel subfamily C member 7
LOW QUALITY PROTEIN: short transient receptor potential channel 7
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X2
heterogeneous nuclear ribonucleoprotein A0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 12 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
family with sequence similarity 13 member B, transcript variant X1
family with sequence similarity 13 member B, transcript variant X3
family with sequence similarity 13 member B, transcript variant X5
family with sequence similarity 13 member B, transcript variant X4
family with sequence similarity 13 member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
NME/NM23 family member 5, transcript variant X2
NME/NM23 family member 5, transcript variant X1
nucleoside diphosphate kinase homolog 5 isoform X1
NME/NM23 family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nucleoside diphosphate kinase homolog 5 isoform X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X1
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X6
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X4
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X5
heterogeneous nuclear ribonucleoprotein A/B isoform X1
heterogeneous nuclear ribonucleoprotein A/B isoform X2
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X2
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X1
5-phosphohydroxy-L-lysine phospho-lyase isoform X2
5-phosphohydroxy-L-lysine phospho-lyase isoform X1
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(XXIII) chain
CDC like kinase 4, transcript variant X3
CDC like kinase 4, transcript variant X1
CDC like kinase 4, transcript variant X4
CDC like kinase 4, transcript variant X2
dual specificity protein kinase CLK4 isoform X1
dual specificity protein kinase CLK4 isoform X2
ras-GEF domain-containing family member 1C
mitogen-activated protein kinase 9, transcript variant X2
mitogen-activated protein kinase 9, transcript variant X3
mitogen-activated protein kinase 9, transcript variant X1
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X3
glutamine-fructose-6-phosphate transaminase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6 isoform X1
CCR4-NOT transcription complex subunit 6 isoform X2
uncharacterized LOC117003246, transcript variant X1
uncharacterized LOC117003246, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 2
RUN and FYVE domain containing 1, transcript variant X1
RUN and FYVE domain-containing protein 1 isoform X1
RUN and FYVE domain containing 1, transcript variant X3
RUN and FYVE domain containing 1, transcript variant X4
RUN and FYVE domain containing 1, transcript variant X2
RUN and FYVE domain-containing protein 1 isoform X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X12
heterogeneous nuclear ribonucleoprotein H1, transcript variant X11
heterogeneous nuclear ribonucleoprotein H1, transcript variant X6
heterogeneous nuclear ribonucleoprotein H1, transcript variant X13
heterogeneous nuclear ribonucleoprotein H1, transcript variant X9
heterogeneous nuclear ribonucleoprotein H1, transcript variant X8
heterogeneous nuclear ribonucleoprotein H1, transcript variant X3
heterogeneous nuclear ribonucleoprotein H1, transcript variant X7
heterogeneous nuclear ribonucleoprotein H1, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, transcript variant X4
heterogeneous nuclear ribonucleoprotein H1, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X14
heterogeneous nuclear ribonucleoprotein H1, transcript variant X10
heterogeneous nuclear ribonucleoprotein H isoform X11
heterogeneous nuclear ribonucleoprotein H isoform X10
heterogeneous nuclear ribonucleoprotein H isoform X5
heterogeneous nuclear ribonucleoprotein H isoform X12
heterogeneous nuclear ribonucleoprotein H isoform X8
heterogeneous nuclear ribonucleoprotein H isoform X7
heterogeneous nuclear ribonucleoprotein H isoform X2
heterogeneous nuclear ribonucleoprotein H isoform X6
heterogeneous nuclear ribonucleoprotein H isoform X1
heterogeneous nuclear ribonucleoprotein H isoform X13
heterogeneous nuclear ribonucleoprotein H isoform X9
heterogeneous nuclear ribonucleoprotein H isoform X3
heterogeneous nuclear ribonucleoprotein H1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H isoform X4
deoxycytidine kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
deoxycytidine kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 12 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mastermind like transcriptional coactivator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X2
TBC1 domain family member 9B, transcript variant X3
TBC1 domain family member 9B, transcript variant X2
TBC1 domain family member 9B, transcript variant X1
ring finger protein 130, transcript variant X2
E3 ubiquitin-protein ligase RNF130 isoform X2
ring finger protein 130, transcript variant X4
ring finger protein 130, transcript variant X1
E3 ubiquitin-protein ligase RNF130 isoform X4
E3 ubiquitin-protein ligase RNF130 isoform X1
ring finger protein 130, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF130 isoform X3
fms related receptor tyrosine kinase 4, transcript variant X3
fms related receptor tyrosine kinase 4, transcript variant X2
fms related receptor tyrosine kinase 4, transcript variant X1
vascular endothelial growth factor receptor 3 isoform X3
vascular endothelial growth factor receptor 3 isoform X2
vascular endothelial growth factor receptor 3 isoform X1
fms related receptor tyrosine kinase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vascular endothelial growth factor receptor 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
HMG-box containing 3, transcript variant X1
HMG-box containing 3, transcript variant X2
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X2
macrophage colony-stimulating factor 1 receptor
platelet derived growth factor receptor beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
platelet derived growth factor receptor beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
platelet-derived growth factor receptor beta isoform X1
platelet derived growth factor receptor beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
platelet-derived growth factor receptor beta isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins
calcium/calmodulin dependent protein kinase II alpha, transcript variant X1
calcium/calmodulin dependent protein kinase II alpha, transcript variant X2
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X2
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
treacle ribosome biogenesis factor 1, transcript variant X1
treacle ribosome biogenesis factor 1, transcript variant X2
treacle ribosome biogenesis factor 1, transcript variant X4
treacle ribosome biogenesis factor 1, transcript variant X5
treacle ribosome biogenesis factor 1, transcript variant X6
treacle ribosome biogenesis factor 1, transcript variant X3
HLA class II histocompatibility antigen gamma chain isoform X3
HLA class II histocompatibility antigen gamma chain isoform X2
HLA class II histocompatibility antigen gamma chain isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
dynactin subunit 4, transcript variant X2
dynactin subunit 4, transcript variant X1
small integral membrane protein 3, transcript variant X2
small integral membrane protein 3, transcript variant X1
TNFAIP3-interacting protein 1-like, transcript variant X2
TNFAIP3-interacting protein 1-like, transcript variant X5
TNFAIP3-interacting protein 1-like, transcript variant X3
TNFAIP3-interacting protein 1-like, transcript variant X6
TNFAIP3-interacting protein 1-like, transcript variant X1
TNFAIP3-interacting protein 1-like, transcript variant X4
TNFAIP3-interacting protein 1-like isoform X4
TNFAIP3-interacting protein 1-like isoform X2
TNFAIP3-interacting protein 1-like isoform X1
TNFAIP3-interacting protein 1-like isoform X5
TNFAIP3-interacting protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
small integral membrane protein 3-like, transcript variant X2
small integral membrane protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cationic amino acid transporter 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 69
proton-coupled amino acid transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 22 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
secreted protein acidic and cysteine rich
G3BP stress granule assembly factor 1, transcript variant X2
G3BP stress granule assembly factor 1, transcript variant X1
ras GTPase-activating protein-binding protein 1 isoform X1
ras GTPase-activating protein-binding protein 1 isoform X2
glycine receptor alpha 1, transcript variant X2
glycine receptor alpha 1, transcript variant X1
glycine receptor subunit alpha-1 isoform X2
glycine receptor subunit alpha-1 isoform X1
uncharacterized LOC117003344, transcript variant X2
uncharacterized LOC117003344, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X3
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 1-like
family with sequence similarity 114 member A2, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X1
microfibril associated protein 3, transcript variant X1
microfibril associated protein 3, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 10 isoform X1
polypeptide N-acetylgalactosaminyltransferase 10, transcript variant X2
polypeptide N-acetylgalactosaminyltransferase 10 isoform X2
histone deacetylase complex subunit SAP30L
heart and neural crest derivatives expressed 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins
heart- and neural crest derivatives-expressed protein 1
La ribonucleoprotein 1, translational regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
La ribonucleoprotein 1, translational regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fatty acid hydroxylase domain containing 2, transcript variant X5
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain containing 2, transcript variant X7
fatty acid hydroxylase domain containing 2, transcript variant X6
fatty acid hydroxylase domain containing 2, transcript variant X4
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain-containing protein 2
CCR4-NOT transcription complex subunit 8
gem-associated protein 5-like, transcript variant X2
gem-associated protein 5-like, transcript variant X3
gem-associated protein 5-like, transcript variant X1
gem-associated protein 5-like isoform X2
gem-associated protein 5-like isoform X3
gem-associated protein 5-like isoform X1
39S ribosomal protein L22, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: la-related protein 1-like
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X5
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X2
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X4
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X3
fatty acid hydroxylase domain-containing protein 2-like, transcript variant X1
fatty acid hydroxylase domain-containing protein 2-like
sarcoglycan delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sarcoglycan delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan delta, transcript variant X5
sarcoglycan delta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sarcoglycan delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sarcoglycan delta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X1
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X2
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X1
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X2
hepatitis A virus cellular receptor 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
hepatitis A virus cellular receptor 1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
hepatitis A virus cellular receptor 1 homolog isoform X2
hepatitis A virus cellular receptor 1 homolog isoform X1
mediator of RNA polymerase II transcription subunit 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic FMR1 interacting protein 2, transcript variant X1
cytoplasmic FMR1 interacting protein 2, transcript variant X5
cytoplasmic FMR1 interacting protein 2, transcript variant X4
cytoplasmic FMR1 interacting protein 2, transcript variant X2
cytoplasmic FMR1 interacting protein 2, transcript variant X3
cytoplasmic FMR1-interacting protein 2 isoform X1
cytoplasmic FMR1-interacting protein 2 isoform X3
cytoplasmic FMR1-interacting protein 2 isoform X2
fibronectin type III domain containing 9
fibronectin type III domain-containing protein 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19
tRNA-histidine guanylyltransferase 1 like, transcript variant X1
probable tRNA(His) guanylyltransferase isoform X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X2
probable tRNA(His) guanylyltransferase isoform X2
LOW QUALITY PROTEIN: U7 snRNA-associated Sm-like protein LSm11
LOW QUALITY PROTEIN: clathrin interactor 1
EBF transcription factor 1, transcript variant X4
EBF transcription factor 1, transcript variant X3
EBF transcription factor 1, transcript variant X2
EBF transcription factor 1, transcript variant X1
EBF transcription factor 1, transcript variant X8
EBF transcription factor 1, transcript variant X7
EBF transcription factor 1, transcript variant X6
EBF transcription factor 1, transcript variant X5
ring finger protein 145, transcript variant X1
ring finger protein 145, transcript variant X2
ring finger protein 145, transcript variant X3
ubiquitin like domain containing CTD phosphatase 1, transcript variant X4
ubiquitin like domain containing CTD phosphatase 1, transcript variant X1
ubiquitin like domain containing CTD phosphatase 1, transcript variant X2
ubiquitin like domain containing CTD phosphatase 1, transcript variant X3
ubiquitin-like domain-containing CTD phosphatase 1
serine protease inhibitor Kazal-type 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
double-headed protease inhibitor, submandibular gland-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ovoinhibitor-like, transcript variant X1
ovoinhibitor-like, transcript variant X2
pancreatic secretory trypsin inhibitor-like
histamine receptor H2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histamine receptor H2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC117003364, transcript variant X2
uncharacterized LOC117003364, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SUMO interacting motifs containing 1, transcript variant X1
SUMO interacting motifs containing 1, transcript variant X3
SUMO interacting motifs containing 1, transcript variant X2
SUMO-interacting motif-containing protein 1 isoform X1
SUMO-interacting motif-containing protein 1 isoform X3
SUMO-interacting motif-containing protein 1 isoform X2
HIG1 hypoxia inducible domain family member 2A
HIG1 domain family member 2A, mitochondrial
clathrin light chain B, transcript variant X2
clathrin light chain B, transcript variant X1
ring finger protein 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ring finger protein 44, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ring finger protein 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ring finger protein 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
G protein regulated inducer of neurite outgrowth 1, transcript variant X1
G protein regulated inducer of neurite outgrowth 1, transcript variant X2
G protein-regulated inducer of neurite outgrowth 1
eukaryotic translation initiation factor 4E family member 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 31 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E type 1B
unc-5 netrin receptor A, transcript variant X3
unc-5 netrin receptor A, transcript variant X2
unc-5 netrin receptor A, transcript variant X4
unc-5 netrin receptor A, transcript variant X1
ubiquitin interaction motif containing 1, transcript variant X2
ubiquitin interaction motif containing 1, transcript variant X3
ubiquitin interaction motif containing 1, transcript variant X4
ubiquitin interaction motif containing 1, transcript variant X1
BRCA1-A complex subunit RAP80 isoform X2
BRCA1-A complex subunit RAP80 isoform X1
BRCA1-A complex subunit RAP80 isoform X3
fibroblast growth factor receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 67 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 59 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor receptor 4 isoform X1
fibroblast growth factor receptor 4 isoform X2
nuclear receptor binding SET domain protein 1, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X1
nuclear receptor binding SET domain protein 1, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X2
nuclear receptor binding SET domain protein 1, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X3
PRELI domain-containing protein 1, mitochondrial
lateral signaling target protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 193 member B
probable ATP-dependent RNA helicase DDX41
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
proline rich 7, synaptic, transcript variant X1
proline rich 7, synaptic, transcript variant X2
G protein-coupled receptor kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 49 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
G protein-coupled receptor kinase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
G protein-coupled receptor kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
G protein-coupled receptor kinase 6 isoform X3
G protein-coupled receptor kinase 6 isoform X1
G protein-coupled receptor kinase 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 23 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent phosphate transport protein 2A
regulator of G protein signaling 14, transcript variant X1
regulator of G-protein signaling 14 isoform X1
regulator of G protein signaling 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
regulator of G-protein signaling 14 isoform X2
ADP-ribosylation factor-like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADP-ribosylation factor-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ADP-ribosylation factor-like protein 3 isoform X1
ADP-ribosylation factor-like protein 3 isoform X2
vesicular integral-membrane protein VIP36
H/ACA ribonucleoprotein complex subunit 2
bromodomain-containing protein 8-like, transcript variant X3
bromodomain-containing protein 8-like, transcript variant X1
bromodomain-containing protein 8-like, transcript variant X2
bromodomain containing 8, transcript variant X2
bromodomain containing 8, transcript variant X1
bromodomain-containing protein 8 isoform X2
bromodomain-containing protein 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC117003169, transcript variant X2
uncharacterized LOC117003169, transcript variant X1
dopamine receptor D1, transcript variant X1
dopamine receptor D1, transcript variant X2
neuronal vesicle trafficking associated 2
neuronal vesicle trafficking-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 79% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytoplasmic polyadenylation element binding protein 4, transcript variant X2
cytoplasmic polyadenylation element binding protein 4, transcript variant X1
cytoplasmic polyadenylation element-binding protein 4 isoform X2
cytoplasmic polyadenylation element-binding protein 4 isoform X1
biorientation of chromosomes in cell division 1
biorientation of chromosomes in cell division protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins
endoplasmic reticulum-golgi intermediate compartment 1
endoplasmic reticulum-Golgi intermediate compartment protein 1
dual specificity phosphatase 1, transcript variant X1
dual specificity phosphatase 1, transcript variant X2
dual specificity protein phosphatase 1 isoform X1
dual specificity protein phosphatase 1 isoform X2
neuralized E3 ubiquitin protein ligase 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SH3 and PX domains 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SH3 and PX domains 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 4 ESTs, 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
SH3 domain and tetratricopeptide repeats 2, transcript variant X4
SH3 domain and tetratricopeptide repeats 2, transcript variant X5
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeats 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X4
SH3 domain and tetratricopeptide repeats 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X5
actin binding LIM protein family member 3, transcript variant X6
actin binding LIM protein family member 3, transcript variant X5
actin binding LIM protein family member 3, transcript variant X1
actin binding LIM protein family member 3, transcript variant X3
actin binding LIM protein family member 3, transcript variant X4
actin binding LIM protein family member 3, transcript variant X2
actin filament associated protein 1 like 1, transcript variant X1
actin filament associated protein 1 like 1, transcript variant X2
actin filament-associated protein 1-like 1 isoform X1
actin filament-associated protein 1-like 1 isoform X2
uncharacterized LOC117003433, transcript variant X2
uncharacterized LOC117003433, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X1
casein kinase 1 alpha 1, transcript variant X3
casein kinase 1 alpha 1, transcript variant X5
casein kinase 1 alpha 1, transcript variant X4
casein kinase 1 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 10 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma coactivator 1-beta
tripartite motif-containing protein 29-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tripartite motif-containing protein 29-like, transcript variant X2
tripartite motif-containing protein 29-like isoform X1
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X2
solute carrier family 26 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 26 member 2, transcript variant X3
solute carrier family 26 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxytryptamine receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X5
5-hydroxytryptamine receptor 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X1
5-hydroxytryptamine receptor 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tetratricopeptide repeat domain 1, transcript variant X1
tetratricopeptide repeat domain 1, transcript variant X2
PWWP domain containing 2A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PWWP domain containing 2A, transcript variant X5
PWWP domain containing 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 ESTs, 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X2
PWWP domain containing 2A, transcript variant X7
PWWP domain-containing protein 2A isoform X3
PWWP domain containing 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PWWP domain-containing protein 2A isoform X2
PWWP domain containing 2A, transcript variant X1
PWWP domain-containing protein 2A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CCHC domain-containing protein 10
heat shock protein family A (Hsp70) member 4
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X1
E3 ubiquitin-protein ligase RNF14 isoform X1
ring finger protein 14, transcript variant X3
E3 ubiquitin-protein ligase RNF14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X1
rho GTPase-activating protein 26 isoform X2
rho GTPase-activating protein 26 isoform X3
nuclear receptor subfamily 3 group C member 1, transcript variant X2
nuclear receptor subfamily 3 group C member 1, transcript variant X1
potassium channel tetramerization domain containing 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD16
glutaredoxin and cysteine rich domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
leucyl-tRNA synthetase 1, transcript variant X2
leucyl-tRNA synthetase 1, transcript variant X1
leucine--tRNA ligase, cytoplasmic isoform X2
leucine--tRNA ligase, cytoplasmic isoform X1
RNA binding motif protein 27, transcript variant X1
RNA binding motif protein 27, transcript variant X3
RNA binding motif protein 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
POU domain, class 4, transcription factor 3
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X4
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X1
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X2
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
serine/threonine kinase 32A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine kinase 32A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
serine/threonine-protein kinase 32A isoform X1
serine/threonine-protein kinase 32A isoform X2
dihydropyrimidinase like 3, transcript variant X1
dihydropyrimidinase like 3, transcript variant X2
dihydropyrimidinase-related protein 3 isoform X1
dihydropyrimidinase-related protein 3 isoform X2
janus kinase and microtubule interacting protein 2, transcript variant X2
janus kinase and microtubule interacting protein 2, transcript variant X3
janus kinase and microtubule interacting protein 2, transcript variant X6
janus kinase and microtubule interacting protein 2, transcript variant X1
janus kinase and microtubule interacting protein 2, transcript variant X4
janus kinase and microtubule interacting protein 2, transcript variant X5
janus kinase and microtubule-interacting protein 2
receptor accessory protein 2, transcript variant X4
receptor accessory protein 2, transcript variant X6
receptor expression-enhancing protein 2 isoform X4
receptor expression-enhancing protein 2 isoform X6
receptor accessory protein 2, transcript variant X5
receptor accessory protein 2, transcript variant X1
receptor accessory protein 2, transcript variant X2
receptor accessory protein 2, transcript variant X3
receptor expression-enhancing protein 2 isoform X1
receptor expression-enhancing protein 2 isoform X2
receptor expression-enhancing protein 2 isoform X3
receptor expression-enhancing protein 2 isoform X5